I. INTRODUCTION
With the continuing reduction in cost, power consumption and size of digital systems comes the increasing opportunity for new implementations and new applications of existing solutions for biomedical instrumentation systems. The high resolution measurement capacity of the 24-bit Sigma-Delta analogue to digital converter [1] , has been combined with suitably powerful digital signal processors to implement commercially available bio-amplification systems which benefit from the digitisation of the instrumentation system [2] . The aim of this work is to review the performance of this instrumentation combination with a view to (1) understanding and analysing the performance of a prototype system itself (2) investigating the cost and size of such a biosignal amplifier based on currently available components.
The aim of this work is to investigate the possible benefits and issues of sampling signals of low amplitude without analogue amplification by employing an inexpensive high resolution analogue to digital converter with suitable reference voltages. More specifically, the idea is to employ an embedded approach using inexpensive but powerful converters and microprocessors or microcontrollers to perform signal processing that would traditionally be performed by analogue amplifier and filter circuits. When this "digital amplifier" approach is incorporated into physiological measurement devices the signal passes through fewer components before it is converted into noise-immune digital form. The small number of components also means that it can be miniaturised and made portable.
The "digital amplifier" approach has been employed within various commercially available biosignal measurement systems. The authors have attempted to show that it is possible to develop a relatively inexpensive "digital amplifier" physiological recording system using off-theshelf components
II. MEASUREMENT SYSTEM OVERVIEW

A. Biopotential signals and their effects on the design of measurement systems
Biopotential signals have amplitudes in the microvolt to millivolt range and spectral components of interest occur in the frequency range from 0.01 Hz to 10kHz. Figure 1 adapted from Bronzino [3] shows approximate spectral ranges and amplitudes for three prominent types of biopotential signals.
To scale the signal from amplitudes of mV or even µV to the 3-10 V range at the input of a typical 12-bit ADC, the signal needs to be amplified. However, depending on the conditions of measurement, the d.c. electrode offset potential (referred to as "d.c. potential" in the graph and placed at 10 -2 Hz for convenience) is often about 100mV and could be up to 1 V for non isolated systems [4] and unless it is dealt with this offset voltage can cause signal distortion or amplifier saturation when biosignals are amplified by typical gains of anything between 100 and 100,000. Table 1 shows some of the general properties of ECG and EEG measurement systems. Gains of over 1000 are generally required over anything from 3 to over 100 channels. The resolution of the analogue to digital converter that is used in a bio-signal measurement system will depend on the application and can range upwards from 8 bits but 12 bits of resolution is typical. In the extreme case of a traditional 128 channel EEG measurement system with mostly discrete components, the chip count is significant. 
B. Biopotential Amplifiers
Electrobiological measurements traditionally employ a high quality analogue bio-potential amplifier which amplifies the differential mode signal between two or more electrodes. Due to the low amplitude of bio-potential signals, the differential mode signal is usually accompanied by comparatively high amplitude common mode noise caused by mains interference, and other bio-signals among other sources. Impedance mismatch between electrodes transforms a small portion of this common mode noise into differential mode noise which is difficult to separate from the desired bio-potential signal. Spinelli et. Al. [4] measured this transfer to be in the millivolt range for common mode voltages that were in volts.
The common mode noise can be reduced by using a combination of shielding or guarding [5] and a circuit arrangement known as 'driven right leg' [6] , [7] . In shielding the common mode voltage is driven onto the protective sheath of the electrode cables and by employing a drivenright-leg. Driven right-leg is a particularly effective approach for common mode rejection which involves inverting and buffering the common mode voltage that appears at the inputs to the bio-potential amplifier and applying it to another electrode on the body of the subject. For electrocardiograms this electrode is affixed to the right leg. The input impedance of bio-potential amplifiers can vary from 10MΩ for ECG amplifiers to 100MΩ for EEG amplifiers. Two other key characteristics are the dynamic range which is the difference in scale from smallest to largest signal that the amplifier can respond to and the ability of the amplifier to recover from transients which may tend to 'swamp' the intended signal
C. The Analogue to Digital Converter (ADC)
The ADC chosen for this work was the ADS1256 from Texas Instruments. [8] This is a low cost, 24 bit (or less, depending on speed) Sigma Delta ADC with a Serial Peripheral Interface (SPI) for interconnection with a host microprocessor. The ADS1256 also incorporates a Programmable Gain Amplifier which facilitates "rangechanging" for different input signal ranges. There are 4 differential (8 single ended) inputs available.
The SPI interface of the ADS1256 allows a host processor to read and set values in internal configuration registers such as setting the actual sampling rate, controlling the multiplexer and reading converter status
D. Interfacing the host processor to the ADC
The processor chosen to interface to the ADC and to provide a communications bridge back to the PC was the Texas Instruments MSP430F149 processor [9] . This is a 16 bit 'RISC-like' processor that runs at 8MHz. The Texas Instruments MSP processor family was designed with particularly low power consumption in mind, making it ideal for mobile, battery powered applications. The MSP430F149 also contains two serial interfaces facilitating its use as a bridge between a high speed serial interface to an ADC and an RS232 link to a PC. The MSP430F149 is a highly integrated processor so a very small number of components are required to produce an operational platform.
MSP430F149 connects to the ADS1256 using a 2MHz SPI link over which control and data information is sent. The MSP430F149 extracts ADC data from the ADS1256, reformats it into a format compatible with a data capture application running on the PC and then transmits it. The Microcontroller outputs the acquired data continuously via its UART1 serial port. A Matlab serial port read command is used to acquire the required number of samples which are saved to a file for later analysis. Results from a number of tests of the system are presented in the next section. 
E. System Analysis and Test
A simple test environment was used to prove the systems performance. A sampled ECG signal generated from an upsampled ECG record from the MIT-BIH Arrythmia database was sent out through a digital to analogue convertor (DAC) channel of an MSP430F439 microcontroller to produce signal to simulate an ECG signal. The DAC on the MSP430F439 has a reconstruction filter which smooths the edges on the analogue signal that is produced by the DAC. The signal from the DAC is then split and passed through different impedances to simulate different signal paths in the chest. Figure 3 shows a block diagram of the test system. The (useful/noise-free) number of bits from the ADS1256 depends upon the sample rate and system noise. The ADS1256 samples internally at 30 thousand samples per second (ksps). The rate at which data is read from the device we shall call the actual sample rate. If the actual sample rate is 1ksps then each sample represents the average of 30 readings at the internal sample rate. Averaging changes the number of effective bits and so with an actual sample rate of less than 100 sps, the resolution is in the region of 24 bits. At 1ksps, the number of effective bits drops to approximately 20. The word 'approximately' is used because internal noise varies with configuration settings and so affects the number of useful bits in the output data. Before looking at the test results it is worth considering the consequences of this variation in resolution, when using the ADS1256 to amplify and sample biosignals. Figure 4 shows the signal plane of the various biosignals this time superimposed on a graph showing the variation in resolution as a function of the Nyquist frequency of the converter. From the graph it can be seen that the sigma-delta converter can record most of the main features in the three types of biosignal. A limiting factor is the size of the electrode offset potential. In the absence of a high pass filter this would saturate once it is amplified towards the 3V / 5V limit of the ADS1256.
In order to sample and serially transmit the biopotential signals, a C-library was written to handle the interface between the MSP430F149 and ADS1256 and the PC. This is available for download on request from the authors.
The approach is similar to an approach that has been proposed in the Programmable Chip EEG project [10]. The results of the tests on the two configurations of the system are shown in Figure 5 and Figure 6 . Figure 5 is composed of three discrete-time signals. The first part of the figure, figure 5a , shows an amplitude-normalized plot of the discretised data used to simulate the ECG signal in the heartbeat simulator. Figure 5b is the amplitude-normalized ECG signal obtained from the two-lead measurement system, Figure 5c (the third trace) displays the normalised plot for the three-lead system. The difference in discrete time scaling is due to the different sampling rates used in the simulator and in the ADS1256-based measurement system which samples the analogue signal emitted by the digital to analogue convertor of the heartbeat simulator at a lower sampling rate.
. Figure 5 . Discrete-time plots of the simulated ECG signal before it is sent to the ADC and the resulting sampled signal as measured for the two lead and three lead systems.
A comparison of the two output signals shows basic similarity between signals with little difference between the signals measured by the two lead and three lead systems although the amplitude of the non-normalized three-lead measurement is about 10% larger than the non normalized two-lead one. Figure 6 shows a fast fourier transform (FFT) of the three signals referred to above. Figure 6a shows the spectrum of the simulated signal, Figure 6b shows the spectrum of the sampled signal from the two lead system and Figure 6c shows the spectrum from the three lead system. Again, the difference in frequency scaling is due to the difference in the sampling rates for simulator and measurement systems. The first peak is the fundamental frequency of the simulated heartbeat (at about 140bpm) and from comparison of the spectra it is apparent that up to frequency sample 800 on the simulated signal, the discrete spectra of the measured. This can be attributed to the low pass effect of the reconstruction filter at the output of the MSP430F439.
III. DISCUSSION
This paper has proposed an experimental system for investigating the use of high resolution (up to 24-bits) analogue to digital convertors in physiological measurement applications. This prototype system has allowed the authors to embark on a range of experiments to investigate the benefits afforded by moving part of the required dynamic range of biopotential amplifiers into a digital environment.
A. Discussion of the relative merits of the digital amplifier approach over an analogue biopotential amplifier
A sigma-delta analogue to digital convertor is a monolithic integrated circuit which although it may require supporting components when used in the front end of a digital biopotential amplifier. The large dynamic range (120dB) of this type of converter at frequencies of up to 1khz suggest its use in the place of analogue circuits with similar dynamic range that are composed of a larger number of discrete components. The resulting miniaturisation allows the converter to be positioned close to the electrode and this in turn has the potential to improve signal to noise ratios.
Once the sampled voltage signal is converted to digital form, it is effectively immune to electrical noise and the sampled signal can be processed and transmitted digitally with no further loss of signal quality, thus providing a relatively stable environment for the signal. As discussed in section II, because the converter samples an unfiltered and unamplified signal in the presence of significant offset drift voltages, there is less risk of saturation of the sampled signal. It also reduces the need for analogue filtering of d.c. components. In addition, because the signal is converted into digital form at an early stage, digital isolation can be used to protect the user. Another benefit of using the sigma delta ADC is the ease of configuration.
While there is no doubt that the ADS1256 is rich in features, the authors have found that it is possible to define a relatively simple API which allows the user to configure the IC for multiple modes of operation at run time. The flexibility and stability of this digital configuration represents in the authors view an improvement over the potential difficulties associated with configuration of exclusively analogue bioamplifier circuits.
In effect, the use of a digital amplifier results in a tradeoff; the switch from analogue to digital signal processing requires less complex circuitry at the expense of increased computational load. The combination of microprocessor and converter acting on the unfiltered signal introduces the possibility of incorporating software self calibration and range changing functionality. The input impedance of the analogue input pins on the ADS1256 with the input buffer enabled is 40MΩ at 500 Hz [8] this input impedance is lower than impedances found on biopotential amplifiers which require input impedances of at least 100M Ω. This problem can be solved by the introduction of a very high impedance amplifier configured as a unity gain buffer for each electrode.
Like many analogue to digital converters, the ADS 1256 employs a multiplexer to switch analogue input channels and so does not sample its input pins simultaneously. Even in the case of differential inputs this results in a phase delay between the sampled versions of the two sides of the signal. One way of overcoming this difficulty would be to tie multiple converters to the same signal lines so that the conversions are synchronised. The authors will investigate this aspect in future work.
It has been mentioned in section II that some physiological amplifiers employ a driven right leg feature where the common mode voltage is inverted and superimposed on the reference voltage. The availability of inexpensive 20-bit digital to analogue converters raises the possibility of developing a "digital driven right leg" or low amplitude perturbation signals which could be used to characterise the electrical properties of the body.
B. Cost and Size of the proposed system
24-bit sigma delta analogue to digital converters such as the multi-channel ADS 1256 are inexpensive, they retail for less than €10. Although the two electrode digital biopotential amplifier presented here could not by any means be considered a complete system, with a component count of five components and comparatively low cost in the authors' view it represents a compact and inexpensive way to 'amplify' a bioelectrical signal.
IV. CONCLUSIONS
This paper has presented an investigation of the use of a low cost, low power consumption combination of a high resolution analogue to digital converter and microcontroller to implement an inexpensive, robust and easily maintained biopotential measurement channel. A working prototype has been demonstrated and initial results have been presented. This system has been developed with a view to its implementation in specialized lower cost portable ambulatory biopotential measure systems.
